3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
28
Rectal Neoplasms
6
Colonic Neoplasms
6
Stomach Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasm Metastasis
3
Neutropenia
2
Neoplasms
2
Colorectal Cancer Metastatic
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Advanced Solid Tumors
2
mCRC
1
Spinocerebellar Degenerations
1
Solid Tumor Cancer
1
Sarcoma, Ewing
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Microsatellite-stable Colorectal Cancer
1
Metastatic Gastric Adenocarcinoma
1
Lung Neoplasms
1
High-grade Extra Pulmonary Neuroendocrine Cancer
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Gastric and Gastroesophageal Junction Adenocarcinoma
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Interventions
Cyclophosphamide
6
Vincristine
3
Temozolomide
3
Radiotherapy
3
Cisplatin
3
Automobiles
3
fludarabine
2
Etoposide
2
Eflornithine
2
Carboplatin
2
omburtamab I-131
1
ibrutinib
1
gallium Ga 68 dotatate
1
etoposide phosphate
1
belzutifan
1
Zoledronic Acid
1
Thiotepa
1
Tamoxifen
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Pemetrexed
1
ONC206
1
Nivolumab
1
Mesna
1
Maintenance Chemotherapy
1
Lomustine
1
Isotretinoin
1
Induction Chemotherapy
1
Hydrocortisone
1
HhAntag691
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
trifluridine tipiracil drug combination
×
1 year
×
Clear all
No trials found.